(RTTNews) - Teva Pharmaceutical Industries Ltd. (TEVA) Monday announced a plan to issue $2 million of senior notes through its special purpose finance subsidiaries. The Israel multinational pharma ...

Teva’s betting big on biosimilars and specialty ... For a company that’s often painted as a problem child in pharma, that’s a pretty decent look. But it’s not all sunshine.

NEW YORK - Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) saw its shares climb 3.7% after the company reported first quarter earnings that beat analyst expectations and raised its full-year guidance.

NEW YORK - Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) saw its shares climb 3.7% after the company reported first quarter earnings that beat analyst expectations and raised its full-year guidance.

Shares of Teva Pharma marginally down 1% in early morning trading, while Alvotech's saw a 5% increase. Alvotech is in charge of development and manufacturing of Selarsdi, while Teva holds the ...

Generic drug giant Teva Pharmaceuticals has agreed to pay $450 million to settle two cases brought by the Department of Justice (DOJ), including one alleging that co-pays it made on behalf of Medicare ...

Teva Pharmaceuticals TEVA0.12%increase; green up pointing triangle will pay $450 million to resolve allegations that the generic drug manufacturer submitted false claims and violated a federal law ...

Big Pharma is able to charge Americans significantly higher prices and pad their profits.” Sen. Elizabeth Warren (D-Mass.) and Rep. Pramila Jayapal (D-Wash.) last month called again on Teva and ...

was filed by McCarter & English and Venable on behalf of UroGen Pharma. The suit takes aim at Teva's application to the FDA to manufacture generic versions of Jelymto before the plaintiff's ...

Teva CEO Richard Francis expressed confidence that the API business could grow more than its current 6% annual rate. The CEO also assured that future M&A activities would be approached ...

Teva announced its intention to divest its active pharmaceutical ingredient business to maximize current and potential revenue streams. Fourth quarter and full year 2023 figures include the impact ...